Regenerative medicine for advanced surgical care

Abstract

Regenerative medicine, or the ability to restore function with autologous products rather than pharmaceuticals, is an important new treatment concept. Despite recent novel developments in stem cell therapy, it could be argued that regenerative medicine is not new at all; transplantation, first done for kidneys in 1954 and hearts in 1967, is regenerative medicine. In the 21st century, however, regenerative medicine is redefined by novel blockbuster therapeutics such as chimeric antigen receptor (CAR) T cell therapy for lymphoma, innovative device design such as the Celution® System (Cytori Therapeutics, San Diego, California, USA) platform technology